ClearPoint: The Hidden Champion of the Gene Therapy Revolution

Precision in Neurosurgery – ClearPoint revolutionizes minimally invasive brain surgery with MRI-guided navigation systems which are already in use in over 65 clinics. Enormous Growth Potential – Analysts expect revenue to double by 2026, while the number of approved gene therapies in the EU could triple by 2030. With a market capitalization of only $0.5 billion, ClearPoint appears to be a small medical technology provider. However, the company has established a nearly unmatched position in the field of MRI-guided neurosurgery and...